2000-2013年本、硕、博就读和工作于南开大学，2013-2015年于美国 Vanderbilt University 和 Georgia Institute of Technology 从事博士后研究，2015年引进至金沙2004路线js5。

担任中国药理学会化疗药理专委会委员，中国抗癌协会肿瘤胃肠病学专委会委员，四川省药理学学会抗肿瘤药物专委会委员，四川省抗癌协会肿瘤标志专委会委员等。

承担本科生“药理学”，硕士研究生和博士研究生“分子药理学”、“临床药理学”以及留学生药理学相关课程的教学工作。获四川省学术和技术带头人后备人选（2021），金沙2004路线js5优秀教师（2018），金沙2004路线js5好未来优秀学者（2018）等称号奖项。

主持国家自然科学基金面上项目2项、省部级基金项目2项以及其他科研基金项目多项。建设“代谢药理学”科研团队，现有教授、副教授2人，中级职称教师及研究生10余人，应用包括代谢异常疾病动物模型和细胞模型等科研体系，从事激素调控代谢的机制研究；从代谢异常引起的氧化应激器官损伤和免疫调节角度，探寻肿瘤、脂肪肝和糖尿病等疾病的分子机制及药物机理；培育医学、药学领域的优秀青年科研/研发人才！

近年部分代表性论文：

1. YH Wang, YL Wang, F Li, J Zou, XQ Li, MX Xu, DJ Yu, YJ Ma, W Huang, XD Sun*, YY Zhang*. Psoralen suppresses lipid deposition by alleviating insulin resistance and promoting autophagy in oleate-induced L02 cells. Cells, 2022; 11(7): 11071067.

2. J Zou, MX Xu, F Li, YH Wang, XQ Li, DJ Yu, YJ Ma, YY Zhang*, and XD Sun*. Icaritin alleviates docetaxel-induced skin injury by suppressing reactive oxygen species via estrogen receptors. Thorac Cancer, 2022; 13(2): 190-201.

3. Y Yang, Y Wu, J Zou, YH Wang, MX Xu, W Huang, DJ Yu, L Zhang, YY Zhang*, XD Sun*. Naringenin attenuates non-alcoholic fatty liver disease by enhancing energy expenditure and regulating autophagy via AMPK. Front Pharmacol, 2021; 12: 687095.

4. Y Wu, Y Yang, F Li, J Zou, YH Wang, MX Xu, YL Wang, RX Li, YT Sun, S Lu, YY Zhang*, XD Sun*. Icaritin attenuates lipid accumulation by increasing energy expenditure and autophagy regulated by phosphorylating AMPK. J Clin Transl Hepatol, 2021; 9(3): 373-383.

5. YL Wang, J Wu, RX Li, YT Sun, YJ Ma, CY Zhao, J Zou, YY Zhang*, XD Sun*. A double-edged sword: the Kelch-like ECH-associated protein 1-nuclear factor erythroid-derived 2-related factor 2-antioxidant response element pathway targeted pharmacological modulation in nonalcoholic fatty liver disease. Curr Opin Pharmacol, 2021; 60: 281-290.

6. CC Tao, Y Yang, F Li, L Qiao, Y Wu, XD Sun, YY Zhang*, CL Li*. Cloning short DNA into plasmids by one‐step PCR. Thoracic Cancer, 2020; 11: 3409-3415.

7. CC Tao, Y Wu, X Gao, L Qiao, Y Yang, F Li, J Zou, YH Wang, SY Zhang, CL Li, YY Zhang*, XD Sun*. The antitumor effects of icaritin against breast cancer is related to estrogen receptors. Curr Mol Med, 2020; 21(1): 73-85.

8. J Yao, F Yang, X Sun, S Wang, N Gan, Q Liu, D Liu, X Zhang, D Niu, Y Wei, C Ma, ZQ Luo, Q Sun, and D Jia. Mechanism of inhibition of retromer transport by the bacterial effector RidL. Proc Natl Acad Sci U S A, 2018; 115(7): E1446-E1454.

9. Y Liu, W Ren, Y Bai, L Wan, X Sun, Y Liu, W Xiong, YY Zhang*, LM Zhou*. Oxyresveratrol prevents murine H22 hepatocellular carcinoma growth and lymph node metastasis via inhibiting tumor angiogenesis and lymphangiogenesis. J Nat Med, 2018; 72(2): 481-492.

10. X Liu, Y Li, X Sun, Y Muftuoglu, B Wang, T Yu, Y Hu, L Ma, M Xiang, G Guo, C You, X Gao, and Y Wei. Powerful anti-colon cancer effect of modified nanoparticle-mediated IL-15 immunogene therapy through activation of the host immune system. Theranostics, 2018; 8(13): 3490-3503.